President Donald Trump has nominated Dr. Casey Means, a physician and health tech entrepreneur, as the next U.S. Surgeon General. The announcement, made Wednesday, highlights Means' alignment with Health Secretary Robert F. Kennedy Jr.’s "Make America Healthy Again" initiative.
Dr. Means, 37, co-founded the health technology company Levels, which uses data from continuous glucose monitors to help users understand how their food choices affect metabolic health. She is a strong advocate for using personalized data to drive healthier lifestyles and is widely seen as a rising voice in the preventive health and biohacking movement.
Her brother, Calley Means, was recently appointed as a White House adviser, focusing on food policy reform and addressing corporate influence on national health trends. Together, the Means siblings have been vocal supporters of reshaping American health through nutrition-focused and tech-driven approaches.
Dr. Means will replace Trump’s previous nominee, Dr. Janette Nesheiwat, who the president announced will now serve in a different senior role within the Department of Health and Human Services alongside Secretary Kennedy.
As Surgeon General, Dr. Means would become the nation’s leading spokesperson on public health, responsible for delivering science-based guidance on disease prevention, wellness, and reducing chronic illness. Her nomination is expected to energize health reform advocates who support lifestyle medicine and digital health innovation.
Trump’s pick signals a continued shift toward preventive care and a broader embrace of alternative health strategies that prioritize nutrition, metabolic awareness, and data-driven wellness tools. The nomination must still be confirmed by the Senate.


RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Trump Announces U.S.–India Trade Deal Cutting Tariffs, Boosting Markets and Energy Ties
Democrats Score Surprise Texas State Senate Win, Fueling Momentum Ahead of 2026 Midterms
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Venezuela and U.S. Move Toward Renewed Diplomatic Relations
Rafah Border Crossing to Reopen for Palestinians as Israel Coordinates with Egypt and EU
Japan Finance Minister Defends PM Takaichi’s Remarks on Weak Yen Benefits
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Cuba and U.S. Resume Limited Diplomatic Communications Amid Rising Tensions
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Christian Menefee Wins Texas Special Election, Narrowing GOP House Majority 



